BioCentury
ARTICLE | Company News

Ligand, Avion deal

September 15, 2014 7:00 AM UTC

Ligand granted Avion undisclosed development and commercialization rights to four undisclosed programs using Ligand's Captisol formulation technology. Ligand will receive an undisclosed upfront paymen...